Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts

Journal of Bone and Mineral Metabolism

Volumn 29, Issue 2, 2011, Pages 149-158

  Liu, Yu Yu ^a   Yao, Wei Min ^a   Wu, Tie ^a   Xu, Bi Lian ^a   Chen, Fang ^b   Cui, Liao ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b Guangzhou Baiyunshan Pharmaceutical Factory   (China)

Author keywords

Captopril; Histomorphometry; Osteoblast; Osteopenia; Ovariectomized rat

Indexed keywords

ALKALINE PHOSPHATASE; BETA ACTIN; CAPTOPRIL; COLLAGEN TYPE 1; DIETHYLSTILBESTROL; MESSENGER RNA; PROSTAGLANDIN E2;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ACTIN GENE; BIOMECHANICS; BONE MASS; BONE METABOLISM; BREAK LOAD; BREAK STRESS; CELL DIFFERENTIATION; COLLAGEN I GENE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ESTROGEN DEFICIENCY; FEMALE; GENE; HOUSEKEEPING GENE; IN VITRO STUDY; IN VIVO STUDY; LOADING TEST; LUMBAR VERTEBRA; MORPHOMETRICS; MUSCULOSKELETAL SYSTEM PARAMETERS; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRABECULAR AREA; TRABECULAR BONE; TREATMENT DURATION; YOUNG MODULUS;

ALKALINE PHOSPHATASE; ANIMALS; BIOMECHANICS; BONE DISEASES, METABOLIC; CAPTOPRIL; CELLS, CULTURED; FEMALE; OSTEOBLASTS; OSTEOGENESIS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79959918261     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-010-0209-9     Document Type: Article

References (36)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785-795
2. Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA (1999) High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet 354:971-975 (Pubitemid 29438401)
3. Dennis MS, Lo KM, McDowall M, West T (2002) Fractures after stroke: frequency, types, and associations. Stroke 33:728-734 (Pubitemid 34203999)
4. Tanko LB, Christiansen C, Cox DA, Geiger J, McNabb MA, Cummings SR (2005) Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20:1912-1920 (Pubitemid 41532776)
5. Browner WS, Seeley DG, Vogt TM, Cummings SR (1991) Nontrauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group. Lancet 338:355-358
6. Gupta G, Aronow WS (2006) Atherosclerotic vascular disease may be associated with osteoporosis or osteopenia in postmenopausal women: a preliminary study. Arch Gerontol Geriatr 43:285-288 (Pubitemid 44233705)
7. Hatton R, Stimpel M, Chambers TJ (1997) Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro. J Endocrinol 152:5-10 (Pubitemid 27026382)
8. Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, Tomita T, Yoshikawa H, Ogihara T, Morishita R (2008) Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 22:2465-2475 (Pubitemid 351948664)
9. Pérez-Castrillón JL, Silva J, Justo I, Sanz A, Martín-Luquero M, Igea R, Escudero P, Pueyo C, Díaz C, Hernández G, Dueñas A (2003) Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: relationship with angiotensin converting enzyme polymorphisms. Am J Hypertens 16:453-459 (Pubitemid 36667799)
10. Asaba Y, Ito M, Fumoto T, Watanabe K, Fukuhara R, Takeshita S, Nimura Y, Ishida J, Fukamizu A, Ikeda K (2009) Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J Bone Miner Res 24:241-250
11. Lau E, Wong S, Lynn H, Leung J, Leung PC, Stone K (2003) Risk factors for low bone mass in elderly men: Mr. Os (Hong Kong, the largest cohort study in Asian men). J Bone Miner Res 18:S251
12. Lynn H, Kwok T, Wong SY, Woo J, Leung PC (2006) Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone (NY) 38:584-588
13. Chen F, Wu T, Cui L, Zhang S (2002) A study on captoprilantagonized osteoporosis induced by retinoic acid in mice and its dose-response effects (in Chinese). Chin Pharmacol Bull 18:572-575 (Pubitemid 35439958)
14. Broulik PD, Tesar V, Zima T, Jirsa M (2001) Impact of antihypertensive therapy on the skeleton: effects of enalapril and AT1 receptor antagonist losartan in female rats. Physiol Res 50:353-358 (Pubitemid 32821681)
15. Stimpel M, Jee WS, Ma Y, Yamamoto N, Chen Y (1995) Impact of antihypertensive therapy on postmenopausal osteoporosis: effects of the angiotensin converting enzyme inhibitor moexipril, 17beta-estradiol, and their combination on the ovariectomyinduced cancellous bone loss in young rats. J Hypertens 13:1852-1856 (Pubitemid 26015831)
16. Masunari N, Fujiwara S, Nakata Y, Furukawa K, Kasagi F (2008) Effect of angiotensin converting enzyme inhibitor and benzodiazepine intake on bone loss in older Japanese. Hiroshima J Med Sci 57:17-25 (Pubitemid 351775695)
17. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
18. Chen M, Lai S, Li L, Chen H, Zheng H (2001) To select and measure the biomechanical properties of bone of rat (in Chinese). Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 18:547-551 (Pubitemid 34035973)
19. Rose GA (1966) Immobilization osteoporosis: a study of the extent, severity, and treatment with hedrofluazide. Br J Surg 53:769-774
20. Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund KE, Transbol I (1980) Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 10:273-279 (Pubitemid 10004130)
21. Cappuccio FP (2001) Thiazide use and reduced sodium intake for prevention of osteoporosis. JAMA 285:2323-2324 (Pubitemid 32424095)
22. Minkowita B, Boskey AL, Lane JM, Pearlman HS, Vigorita VJ (1991) Effects of propranolol on bone metabolism in the rat. J Orthop Res 9:869-875
23. Pasco JA, Henry MJ, Sanders KM, Kotowicz MA, Seeman E, Nicholson GC, Geelong Osteoporosis Study (2004) Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study. J Bone Miner Res 19:19-24 (Pubitemid 41295133)
24. Hagiwara H, Hiruma Y, Inoue A, Yamaguchi A, Hirose S (1998) Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells. J Endocrinol 156:543-550 (Pubitemid 28131472)
25. Imai S, Tokunaga Y, Maeda T, Kikkawa M, Hukuda S (1997) Calcitonin gene-related peptide substance p- and tyrosine hydroxylase-immunoreactive innervation of bone marrows: an immunohistochemical and ultrastructural investigation on possible efferent and afferent mechanisms. J Orthop Res 15:133-140 (Pubitemid 27111212)
26. Togari A (2002) Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech 58:77-84 (Pubitemid 34778973)
27. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305-317 (Pubitemid 35345151)
28. Cherruau M, Facchinetti P, Baroukh B, Saffar JL (1999) Chemical sympathectomy impairs bone resorption in rats: a role for the sympathetic system on bone metabolism. Bone (NY) 25:545-551 (Pubitemid 29469460)
29. Imai S, Matsusue Y (2002) Neuronal regulation of bone metabolism and anabolism: calcitonin gene-related peptide-, substance P-, and tyrosine hydroxylase-containing nerves and the bone. Microsc Res Tech 58:61-69 (Pubitemid 34778971)
30. Carey RM, de Siragy HM (2003) Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 24:261-271 (Pubitemid 36733542)
31. Strawn WB, Richmond RS, Ann Tallant E, Gallagher PE, Ferrario CM (2004) Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. Br J Haematol 126:120-126 (Pubitemid 38859492)
32. Nishiya Y, Kosaka N, Uchii M, Sugimoto S (2002) A potent 1, 4-dihydropyridine L-type calcium channel blocker, benidipine, promotes osteoblast differentiation. Calcif Tissue Int 70:30-39 (Pubitemid 36934734)
33. Raisz LG, Fall PM, Gabbitas BY, McCarthy TL, Kream BE, Canalis E (1993) Effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: role of insulin-like growth factor-I. Endocrinology 133:1504-1510 (Pubitemid 23295172)
34. Hakeda Y, Nakatani Y, Hiramatsu M, Kurihara N, Tsunoi M, Ikeda E, Kumegawa M (1985) Inductive effects of prostaglandins on alkaline phosphatase in osteoblastic cells, clone MC3T3-E1 (in Japanese). J Biochem (Tokyo) 97:97-104 (Pubitemid 15158952)
35. Lamparter S, Kling L, Sehrader M, Ziegler R, Pfeilschifter J (1998) Effect of angiotensin II on bone cells in vitro. J Cell Physiol 175:89-98 (Pubitemid 28101975)
36. Grant FD, Mandel SJ, Brown EM, Williams GH, Seely EW (1992) Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems. J Clin Endocrinol Metab 75:988-992